As global markets navigate a period of uncertainty, with trade policies and inflation rates drawing significant attention, Asian economies are also contending with their unique challenges and opportunities. In this environment, growth companies in Asia with strong insider ownership can offer potential resilience and alignment of interests between management and shareholders.
Name | Insider Ownership | Earnings Growth |
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) | 23.3% | 26% |
Seojin SystemLtd (KOSDAQ:A178320) | 32.1% | 34.3% |
Laopu Gold (SEHK:6181) | 36.4% | 45.7% |
Global Tax Free (KOSDAQ:A204620) | 20.4% | 89.3% |
Schooinc (TSE:264A) | 21.6% | 68.9% |
Zhejiang Leapmotor Technology (SEHK:9863) | 15.2% | 61.4% |
HANA Micron (KOSDAQ:A067310) | 18.3% | 125.9% |
Fulin Precision (SZSE:300432) | 13.6% | 78.6% |
Ascentage Pharma Group International (SEHK:6855) | 17.9% | 60.9% |
Synspective (TSE:290A) | 13.2% | 37.4% |
Let's review some notable picks from our screened stocks.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: J&T Global Express Limited, with a market cap of HK$54.55 billion, is an investment holding company that provides express delivery services.
Operations: The company's revenue segments include Transportation - Air Freight, which generated $10.26 billion.
Insider Ownership: 18.9%
Earnings Growth Forecast: 31.4% p.a.
J&T Global Express, trading at 57% below its estimated fair value, has demonstrated significant growth potential with earnings forecasted to increase 31.36% annually over the next three years, outpacing the Hong Kong market. The company recently turned profitable, reporting a net income of US$113.7 million for 2024 compared to a substantial loss in the prior year. Revenue growth is expected to continue at 10.4% per year, surpassing market averages despite low projected return on equity.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AAC Technologies Holdings Inc. is an investment holding company that offers solutions for smart devices across various regions including Mainland China, Hong Kong, Taiwan, other Asian countries, the United States, and Europe with a market cap of HK$63.13 billion.
Operations: The company's revenue segments include CN¥8.28 billion from Electromagnetic Drives and Precision Mechanics, CN¥7.64 billion from Acoustics Products, CN¥4.07 billion from Optics Products, and CN¥920.28 million from Sensor and Semiconductor Products.
Insider Ownership: 37%
Earnings Growth Forecast: 20.6% p.a.
AAC Technologies Holdings, with substantial insider ownership, is positioned for significant growth, driven by a forecasted 20.6% annual earnings increase over the next three years, outpacing the Hong Kong market. Recent unaudited earnings guidance indicates a profit surge of up to 145% year-on-year for 2024. This growth is supported by advancements in optics and acoustics across various sectors like automotive and consumer electronics, enhancing product offerings and operational efficiency amid a recovering global smartphone market.
Simply Wall St Growth Rating: ★★★★★★
Overview: Eyebright Medical Technology (Beijing) Co., Ltd. operates in the medical technology sector, focusing on innovative healthcare solutions, with a market cap of CN¥18.51 billion.
Operations: The company generates its revenue from the Medical Products segment, amounting to CN¥1.41 billion.
Insider Ownership: 20.9%
Earnings Growth Forecast: 27.8% p.a.
Eyebright Medical Technology (Beijing) demonstrates robust growth potential, with earnings rising 27.4% last year and forecasted to grow at 27.8% annually, outpacing the Chinese market. The recent approval of its Loong Crystal PR intraocular lens highlights its commitment to innovation in ophthalmic solutions. Despite no substantial insider trading activity in the past three months, high insider ownership aligns interests with shareholders as the company continues expanding its domestic presence and enhancing brand recognition.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
English